Extreme Movers: Perplexity's picks for 2026-10-07
Perplexity picked OPCH, STX, GH, MRNA, WDC for a 1-day horizon. Average directional return: +0.25%. Directions called correctly: 40%.
| Experiment | Extreme Movers |
|---|---|
| Model | Perplexity |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-07 |
| Measured to | 2026-10-08 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | +0.25% |
| Directions called correctly | 40% |
| Benchmark return | +0.21% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | OPCH | up | +0.18% | +0.18% | 72% | -0.03% | Yes |
| 2 | STX | up | -0.24% | -0.24% | 58% | -0.45% | No |
| 3 | GH | up | -2.47% | -2.47% | 55% | -2.68% | No |
| 4 | MRNA | up | +3.93% | +3.93% | 50% | +3.72% | Yes |
| 5 | WDC | up | -0.17% | -0.17% | 52% | -0.38% | No |
The model's market view
US equities entered the one-day window with a constructive backdrop, but the extreme-mover universe is dominated by an M&A re-rating in Option Care Health and a speculative selloff across hard-disk-drive names. I favor mean reversion in the heavily sold storage names and a limited continuation higher in OPCH toward its announced acquisition price.
Why each pick
OPCH
OPCH was the leading gainer in the source session, rising 32.65% after CD&R and McKesson announced a definitive agreement to acquire the company for $32.05 per share. This is a substantive catalyst: the reference price of $31.00, the latest regular-session close found (October 6, roughly one day stale), leaves about 3.4% upside to the deal price, supporting continuation higher subject to deal-completion risk. The stock passed the price and market-cap screens, with $31.00 price and $4.64B market capitalization; its single-session volume of 65.08 million shares implies dollar turnover far above the $20M liquidity floor, although I could not verify the precise 20-day average dollar volume. Main risk is a prolonged regulatory or shareholder-approval timeline, which could keep the shares below the deal price.
STX
STX fell 9.18% in the source session amid reports that Seagate is competing with Toshiba for TDK's HDD magnetic-head business. The catalyst is primarily speculative: it concerns a potential acquisition contest and competitive positioning rather than a confirmed change to Seagate's earnings or guidance. After a prior sharp sector selloff and with analyst commentary framing the pullback as a buying opportunity, I expect a reversal higher. The latest price verified was $805.63 at the October 6 close, with a $183.19B market capitalization and 7.28 million shares traded that day, implying liquidity well above the floor; the exact 20-day average dollar volume was not independently verified. Risks include further escalation of the Toshiba competitive narrative and a high valuation after a major rally.
GH
GH declined 8.83% in the source session, but the available news flow did not identify a comparable substantive negative company-specific catalyst; recent items were positive, including publication of COSMOS melanoma study results and a Guggenheim price-target increase to $200. I therefore treat the decline as a momentum-driven reversal candidate rather than a continuation. The latest verified regular-session close was $170.69, market capitalization was $22.91B, and the session's 3.39 million shares traded at roughly $578M of value, comfortably above the liquidity threshold; the precise 20-day average dollar volume was not verified. Risks are continued high valuation, GAAP losses, and patent-litigation exposure.
MRNA
MRNA fell 7.75% in the source session as investors reassessed sentiment around the vaccine maker, according to the market-mover coverage located. The catalyst appears more sentiment- and positioning-driven than tied to a newly verified operational setback, so I select a reversal higher. I could not verify a current quote, market capitalization, or 20-day average dollar volume within the research available, so those fields are omitted rather than estimated; MRNA is retained because it is a widely traded US-listed common stock and the source-session percentage change was verified. The principal risk is that the selloff reflects a durable deterioration in commercial or pipeline expectations rather than transient sentiment.
WDC
WDC declined 6.93% in the source session alongside Seagate on reports involving Toshiba's potential expansion in the HDD market and a reported contest for TDK's magnetic-head business. Like STX, the immediate catalyst is speculative rather than a confirmed earnings event, and the sector had already experienced a sharp selloff, creating scope for a rebound. I could not verify WDC's latest traded price, market capitalization, or 20-day average dollar volume in the data accessible, so those fields are omitted rather than guessed; the source-session change was verified through the market-mover coverage. Risks include a genuine competitive-capacity threat from Toshiba and continued correlation with the wider storage-hardware selloff.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Gemini 1.5 Pro | OPCH, CIEN, TLN, TWST, CEG | -1.45% | 40% |
| Grok 4.5 | OPCH, CEG, CIEN, TWST, TXG | +0.60% | 60% |
| Claude Sonnet 5.5 | CEG, MRNA, STX, MRVL, OPCH | +1.67% | 80% |
| GPT-5.6 Sol | OPCH, VST, LW, CEG, STX | -0.70% | 60% |
| DeepSeek | PENG, STX, CEG, VST, OPCH | -1.56% | 40% |
Written up on ForecastNest Insights: Extreme Movers: Perplexity's picks for 2026-10-07.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.